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HIV-1 infects CD4+ cells via interaction with CD4 and
either CCR5 or CXCR4. However, only CCR5-using (R5)
viruses are efficiently transmitted and sustain the viral
pandemics, while CXCR4-using (X4) viruses emerge later
in coincidence with the immunodeficiency state and pro-
gression to AIDS in about 50% of individuals infected
with subtype B HIV-1, but not with other subtypes.
Unraveling cellular and molecular correlates of this asym-
metric co-receptor use would be relevant to understand
HIV pathogenesis as well as for the development of pre-
ventive strategies aimed at blocking R5 HIV-1 spreading.
We have previously reported that cord blood derived
CD4+T cells (CB4 cells) maintained in a sub-optimally
activated state in IL-2 enriched medium for 7-14 days
before infection are permissive for R5 and restricted for X4
HIV-1 replication. Of interest, this restriction did not
occur at the level of viral entry, but it was rather correlated
to a superior capacity of R5 HIV-1 to spread after infection
[1]. In the present study, we examined the transcriptomic
profile at different time points (8, 24, 48, 72 h) of CB4
cells established from 6 independent donor/infection
pairs after infection with isogenic NL4-3 (X4) and NL-
AD8 (R5) viruses normalized for MOI. Gene expression
was measured using Human Genome U95A chips and
analyzed with the DAVID knowledge base software.
Approximately 900 and 1,100 genes were selectively
mobilized by R5 and X4 HIV-1 infection, respectively, vs.
mock-stimulated uninfected control cells. An additional
420 genes were modulated by both viruses vs. controls. R5
HIV-1 induced a rapid mobilization of genes linked to cell
proliferation and signal transduction, whereas the X4
virus predominantly modulated the expression of genes
associated with cell death and the immune response. Both
viruses upregulated the expression of CXCL12/SDF-1α,
but only X4 downregulated CXCR4 mRNA; CCR5 mRNA
was unaffected by either infection at all time points. Other
genes previously linked to control of HIV replication that
were modulated by R5 and X4 HIV-1 include APOBEC-
3G, IFN-γ, CCL5/RANTES, CCL7/MCP-3 and CCL14/
HCC1. We are currently analyzing additional genes dis-
cordantly co-modulated by R5 and X4 viruses in the
search of host genes associated with the permissive vs.
restricted HIV replicative profile in this model system.
Thus, both R5 and X4 HIV-1 profoundly affect the tran-
scriptional activity of primary CD4+T lymphocytes even in
the absence of overt replication (as observed in X4 infec-
tion).
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